Clinical, Genomic, and Immunological Characterization of RSV Surge in Sydney, Australia, 2022
Description
CONCLUSIONS: Collectively, these findings suggest that neither the emergence of a novel RSV genotype nor hypothesized immune debt was associated with the surge of RSV cases and hospitalizations in 2022. Continued genomic and immunologic surveillance
